Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial

OBJECTIVE: To examine whether treatment with epigallocatechin gallate (EGCG) influences progression of brain atrophy, reduces clinical and further radiologic disease activity markers, and is safe in patients with progressive multiple sclerosis (PMS). METHODS: We enrolled 61 patients with primary or...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurol Neuroimmunol Neuroinflamm
Autori principali: Rust, Rebekka, Chien, Claudia, Scheel, Michael, Brandt, Alexander U., Dörr, Jan, Wuerfel, Jens, Klumbies, Katharina, Zimmermann, Hanna, Lorenz, Mario, Wernecke, Klaus-Dieter, Bellmann-Strobl, Judith, Paul, Friedemann
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7954462/
https://ncbi.nlm.nih.gov/pubmed/33622766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000964
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi